SCYNEXIS’ License Agreement With GSK for Brexafemme

Cooley advised SCYNEXIS on the deal.SCYNEXIS announced its exclusive license agreement with GSK for Brexafemme.  The exclusive license agreement gives GSK rights to commercialize SCYNEXIS’ ibrexafungerp –…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now